This is my archive

10 Okt 2017

”Animas will continue to sell pumps and operate as usual”

Animas, en af ​​Johnson & Johnson-koncernens diabetesvirksomheder, har meddelt, at de har til hensigt at ophøre med salg i USA og Canada af Animas® Vibe® og OneTouch Ping® insulinpumperne. For patienter og sundhedsudbydere i Skandinavien og EU, dvs. udenfor USA…

Läs mer

09 maj 2017

Latest news on Eversense®

RECENT HIGHLIGHTS & ACCOMPLISHMENTS: Broadening commercial launch in Germany and Sweden with distributors planning to be in eight European countries by mid-year 2017. Received CE Mark for the second generation Eversense® Smart Transmitter in February 2017. This redesigned transmitter is…

Läs mer